Baxter International Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 29.99
Dividend & Yield1.16$ (2.90%)
Beta 0.55
Market capitalization 20.16B
Operating cash flow 1.21B
ESG Scores 23.7

Company description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial Ratios
Quick Ratio1.52
Working Capital0.28
Return On Equity0.14
Debt To Equity1.88
Fixed Asset Ratio0.27
Fixed Interest Cover10.15

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities -23M 57M 104M -76M
Total Cashflows From Investing Activities -1.1B -1.18B -11.2B -931M
Net Borrowings 1.88B 478M 9.33B -899M
Total Cash From Financing Activities 498M -345M 8.24B -1.44B
Change To Operating Activities -354M -48M -58M -440M
Issuance Of Stock 356M 202M 187M 127M
Net Income 1B 1.1B 1.28B -2.43B
Change In Cash 1.5B 401M -780M -1.23B
Effect Of Exchange Rate -5M 57M -47M -76M
Total Cash From Operating Activities 2.1B 1.87B 2.22B 1.21B
Depreciation 784M 823M 890M 1.4B
Change To Account Receivables -52M -119M -170M -146M
Other Cashflows From Financing Activities -48M -52M -138M -61M
Change To Netincome 744M 215M 209M 3.26B
Capital Expenditures -696M -709M -743M -679M

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development 561M 519M 533M 602M
Income Before Tax 970M 1.29B 1.48B -2.35B
Net Income 1B 1.1B 1.28B -2.43B
Selling General Administrative 2.44B 2.4B 2.63B 3.57B
Gross Profit 4.82B 4.63B 5.25B 6.03B
Ebit 1.82B 1.71B 2.09B 1.85B
Operating Income 1.82B 1.71B 2.09B 1.85B
Interest Expense -111M -153M -158M -415M
Income Tax Expense -41M 182M 182M 68M
Total Revenue 11.36B 11.67B 12.78B 15.11B
Cost Of Revenue 6.54B 7.04B 7.53B 9.08B
Total Other Income ExpenseNet -852M -421M -610M -4.21B
Net Income From Continuing Ops 1.01B 1.11B 1.29B -2.42B
Net Income Applicable To Common Shares 1B 1.1B 1.28B -2.43B

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 10.28B 11.29B 24.4B 22.39B
Total Stockholder Equity 7.88B 8.69B 9.08B 5.83B
Other Current Liabilities 874M 923M 1.21B 1.19B
Total Assets 18.19B 20.02B 33.52B 28.29B
Common Stock 683M 683M 683M 683M
Other Current Assets 619M 688M 755M 823M
Retained Earnings 15.72B 16.33B 17.07B 14.05B
Treasury Stock -14.47B -14.37B -14.87B -15.22B
Cash 3.33B 3.73B 2.95B 1.72B
Total Current Liabilities 3.23B 3.33B 4.24B 4.75B
Other Stockholder Equity -3.71B -3.31B -3.38B -3.83B
Property, Plant, and Equipment 5.12B 5.33B 5.81B 5.53B
Total Current Assets 7.5B 8.41B 8.87B 8.01B
Net Tangible Assets 3.38B 3.8B -8.55B -7.8B
Net Receivables 1.9B 2.08B 2.71B 2.75B
Accounts Payable 892M 1.04B 1.25B 1.14B


Insider Transactions

Here are the insider transactions of stock shares related to Baxter International Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
KUNZLER JACQUELINESale at price 40.50 per share.D2023-02-21Officer3.81k
KUNZLER JACQUELINEConversion of Exercise of derivative security at price 37.82 per share.D2023-02-21Officer4.16k
ALMEIDA JOSE E.Stock Award(Grant) at price 0.00 per share.D2023-02-13Chief Executive Officer31.04k
MASON JEANNE KStock Award(Grant) at price 0.00 per share.D2023-02-13Officer3.62k
STEVENS BRIANStock Award(Grant) at price 0.00 per share.D2023-02-13Officer646
SACCARO JAMESStock Award(Grant) at price 0.00 per share.D2023-02-13Chief Financial Officer3.36k
FRANZI CRISTIANOStock Award(Grant) at price 0.00 per share.D2023-02-13Officer5.17k
KUNZLER JACQUELINEStock Award(Grant) at price 0.00 per share.D2023-02-13Officer2.07k
FLYNN STEVENStock Award(Grant) at price 0.00 per share.D2023-02-13Officer516
MASON JEANNE KSale at price 44.70 per share.D2023-01-17Officer59.48k
MASON JEANNE KConversion of Exercise of derivative security at price 37.82 per share.D2023-01-17Officer59.48k
ROSENBLOOM DAVID SStock Award(Grant) at price 0.00 per share.D2022-06-01General Counsel41.58k
WILVER PETER MStock Award(Grant) at price 0.00 per share.D2022-05-10Director2.48k
SHAFER DAVID BRENTStock Award(Grant) at price 0.00 per share.D2022-05-10Director2.48k
HELLMAN PETER SStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
STROUCKEN ALBERT P LStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
OESTERLE STEPHEN NStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
MORRISON PATRICIA BStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
SMITH CATHERINE RStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
CHEN THOMAS FANG TYANStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
SCHLICHTING NANCY MStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
MCBRIDE-WENDELL AMY A.Stock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
MAHONEY MICHAEL FStock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
WILKES DAVID S. M.D.Stock Award(Grant) at price 0.00 per share.D2022-05-03Director2.71k
HELLMAN PETER SSale at price 75.76 - 76.63 per share.D2022-04-05Director4.02k
HELLMAN PETER SConversion of Exercise of derivative security at price 29.52 per share.D2022-04-05Director4.02k
STROUCKEN ALBERT P LSale at price 75.76 - 76.63 per share.D2022-04-05Director4.02k
STROUCKEN ALBERT P LConversion of Exercise of derivative security at price 29.52 per share.D2022-04-05Director4.02k
FORSYTH JOHN DSale at price 77.68 per share.D2022-04-01Director1k
FORSYTH JOHN DConversion of Exercise of derivative security at price 29.52 per share.D2022-04-01Director1k
ALMEIDA JOSE E.Stock Award(Grant) at price 0.00 per share.D2022-03-02Chief Executive Officer32.7k
MASON JEANNE KStock Award(Grant) at price 0.00 per share.D2022-03-02Officer5.05k
BORZI JAMES WStock Award(Grant) at price 0.00 per share.D2022-03-02Officer4.16k
MARTIN SEAN B. W.Stock Award(Grant) at price 0.00 per share.D2022-03-02General Counsel6.69k
STEVENS BRIANStock Award(Grant) at price 0.00 per share.D2022-03-02Officer12.48k
SACCARO JAMESStock Award(Grant) at price 0.00 per share.D2022-03-02Chief Financial Officer10.7k
ACCOGLI GIUSEPPEStock Award(Grant) at price 0.00 per share.D2022-03-02Chief Operating Officer11.89k
FRYE ANDREW RICHARDStock Award(Grant) at price 0.00 per share.D2022-03-02Officer7.43k
FRANZI CRISTIANOStock Award(Grant) at price 0.00 per share.D2022-03-02Officer8.18k
KUNZLER JACQUELINEStock Award(Grant) at price 0.00 per share.D2022-03-02Officer2.97k
FORSYTH JOHN DSale at price 84.82 per share.D2022-03-01Director1k
FORSYTH JOHN DConversion of Exercise of derivative security at price 29.52 per share.D2022-03-01Director1k
STEVENS BRIANSale at price 85.46 - 86.07 per share.D2022-02-28Officer2.5k
MASON JEANNE KSale at price 84.75 - 85.54 per share.D2022-02-14Officer54.14k
MASON JEANNE KConversion of Exercise of derivative security at price 30.95 per share.D2022-02-14Officer54.14k
ALMEIDA JOSE E.Stock Award(Grant) at price 0.00 per share.D2022-02-10Chief Executive Officer39.01k
MASON JEANNE KStock Award(Grant) at price 0.00 per share.D2022-02-10Officer5.19k
MARTIN SEAN B. W.Stock Award(Grant) at price 0.00 per share.D2022-02-10General Counsel6.24k
STEVENS BRIANStock Award(Grant) at price 0.00 per share.D2022-02-10Officer973
SACCARO JAMESStock Award(Grant) at price 0.00 per share.D2022-02-10Chief Financial Officer10.14k
ACCOGLI GIUSEPPEStock Award(Grant) at price 0.00 per share.D2022-02-10Chief Operating Officer8.58k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Baxter International Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Baxter International Inc

Here is the result of two systematic investment strategies applied to Baxter International Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Baxter International Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Baxter International Inc:

Baxter International Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0.6% on the backtest period.

Performance at glance

Performance

0.6 %

Latent gain

13.6 $

Invested capital

2250.2 $

Annualized return

0.14 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Baxter International Inc

This is the result of two momentum investment strategies applied to Baxter International Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Baxter International Inc

The following chart shows all the entries opened by the momentum investment system on Baxter International Inc:

Baxter International Inc momentum entries
  • The first momentum investment strategy would give 8.73% of return on Baxter International Inc. That represents 428.59$ of latent gain with 4907.51$ of employed capital.
  • The second momentum investment strategy would give 4.69% of return on Baxter International Inc. That represents 239.26$ of latent gain with 5096.84$ of employed capital.
Performance at glance (1Q Momentum)

Performance

8.73 %

Latent gain

428.59 $

Invested capital

4907.51 $

Annualized return

1.09 %
Performance at glance (2Q Momentum)

Performance

4.69 %

Latent gain

239.26 $

Invested capital

5096.84 $

Annualized return

1.28 %

Momentum equity curve on Baxter International Inc

The following chart shows the equity curve of the two momentum strategies applied to Baxter International Inc:

Baxter International Inc momentum equity

Note: the dividends potentially given by Baxter International Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Baxter International Inc

The following chart shows the employed capital evolution of the two momentum strategies on Baxter International Inc since the beginning:

Baxter International Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Baxter International Inc

Buy the dip entry openings on Baxter International Inc

Baxter International Inc

The performance achieved by the robo-advisor on Baxter International Inc is 2.34%. That represents 11.07$ of latent gain with 474.03$ of employed capital. The following chart shows Baxter International Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Baxter International Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

2.34 %

Latent gain

11.07 $

Invested capital

474.03 $

Annualized return

1.09 %

Equity curve of the strategy applied to Baxter International Inc

The following chart shows the result of the investment strategy applied to Baxter International Inc:

Baxter International Inc

Note: the dividends potentially given by Baxter International Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Baxter International Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Baxter International Inc:

Baxter International Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Baxter International Inc

In this section, I will compare the three previous investment strategies applied to Baxter International Inc.

Equity curve comparison on Baxter International Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Baxter International Inc investment strategy comparison

Employed capital comparison on Baxter International Inc

Baxter International Inc investment comparison

Performance comparison on Baxter International Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0.6% 13.6$ 2250.2$ 0.14%
Momentum 1 quarter 8.73% 428.59$ 4907.51$ 2.24%
Momentum 2 quarters 4.69% 239.26$ 5096.84$ 1.28%
Non-directional 2.34% 11.07$ 474.03$ 1.09%
Annualized return comparison

Automatic investment

0.14 %

Momentum 1Q

1.28 %

Momentum 2Q

1.28 %

Non-directional

1.09 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Baxter International Inc:

Note: The algorithm computes the probability of correlation between Baxter International Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Baxter International Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Baxter International Inc
Country United States
City Deerfield
Address One Baxter Parkway
Phone 224 948 2000
Website www.baxter.com
FullTime employees 60000
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XNYS
Ticker BAX
Market www.nyse.com

Baxter International Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 2.8
Peer Environment Performance 2.2440350877193
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 13.6
Peer Social Performance 12.085087719298
Social Percentile unknown
Highest Controversy 3
Peer Highest Controversy Performance 1.9310344827586
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic no
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 7.3
Peer Governance Performance 7.7398245614035
Governance Percentile unknown

ESG at glance
Total ESG Scores: 23.7
Environment Score: 2.8
Social Score: 13.6
Governance Score: 7.3

ESG Performance: AVG_PERF

Peer Group: Healthcare

Peer Esg Score Performance: 22.091551724138

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 39